Australia markets closed

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.83-0.06 (-0.94%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.40M
Enterprise value 8.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.82
Price/book (mrq)3.05
Enterprise value/revenue 14.23
Enterprise value/EBITDA -0.40

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-92.16%
S&P500 52-week change 321.08%
52-week high 3100.80
52-week low 34.43
50-day moving average 37.54
200-day moving average 320.65

Share statistics

Avg vol (3-month) 313.74k
Avg vol (10-day) 310.86k
Shares outstanding 51.58M
Implied shares outstanding 61.58M
Float 8591.01k
% held by insiders 16.77%
% held by institutions 141.70%
Shares short (15 Apr 2024) 416.23k
Short ratio (15 Apr 2024) 41.5
Short % of float (15 Apr 2024) 41.96%
Short % of shares outstanding (15 Apr 2024) 41.02%
Shares short (prior month 15 Mar 2024) 48.79k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 320 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,014.91%

Management effectiveness

Return on assets (ttm)-246.44%
Return on equity (ttm)-1,405.34%

Income statement

Revenue (ttm)570k
Revenue per share (ttm)1.23
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -22.77M
Net income avi to common (ttm)-20.25M
Diluted EPS (ttm)-43.68
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.53M
Total cash per share (mrq)1.25
Total debt (mrq)247k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.57
Book value per share (mrq)-2.59

Cash flow statement

Operating cash flow (ttm)-17.23M
Levered free cash flow (ttm)-11.11M